Various Publications Under the Chemicals Management Plan
Advocacy & Action
US FDA Public Workshop: The Non-prescription Drug Facts Label in a Changing Consumer Marketplace 2021”
Forward Regulatory Plan – Amendments to the Cosmetics Regulations
CETA Enables GMP Certificates of Compliance for Regulatory Audits Outside of their Jurisdictions
Canada’s approach to onsite inspections during COVID-19: Notice
2020 Annual Surveillance Report from Health Canada’s Consumer Product Safety Program
Nitrosamine Update to Market Authorisation Holders of Human Pharmaceutical Products
Auditor General’s 2021 Report – Natural Health Products Program Released
Voluntary Information Gathering on Industry Supply Chain Information Sharing in Canada
An update on the proposed environmental risk assessment regulatory regime for drugs
